Demonstrating the regulatory potential of MIR128-1 in overcoming letrozole resistance in ER-positive breast cancer, Masri et al. (2012) conducted an in vivo experiment using MCF-7 breast cancer cell lines overexpressing the aromatase gene (Table 1). This evidence concerns the gene CYP19A1 and breast carcinoma.